A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
08/2011
08/16/2011	CA2614603C Azolo triazines and pyrimidines
08/16/2011	CA2507716C Novel adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof
08/16/2011	CA2496731C Novel benzonaphthyridines
08/16/2011	CA2456648C Human antibodies specific for interleukin 15 (il-15)
08/16/2011	CA2376164C Intermolecularly associating compounds, and aggregates comprising them
08/12/2011	DE202010007074U1 Neue Darreichungsformen für Cineol New forms of cineole
08/11/2011	WO2011097581A2 THE USE OF PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) AND PACAP ANALOGS AS ADJUNCTIVE TREATMENTS WITH INHIBITORS OF CALCINEURIN OR INHIBITORS OF THE MAMMALIAN TARGET OF RAPAMYCIN (mTOR) COMPLEXES
08/11/2011	WO2011097571A2 Methods for the use of progestogen as a glucocorticoid sensitizer
08/11/2011	WO2011097527A2 Immunoprotection of therapeutic moieties using enhanced fc regions
08/11/2011	WO2011097087A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors
08/11/2011	WO2011096809A1 Use of sialyl oligosaccharides to modulate the immune system
08/11/2011	WO2011096536A1 Novel synthetic glycolipid and use thereof
08/11/2011	WO2011096504A1 Method for producing nk cell enhancement-type blood product
08/11/2011	WO2011096490A1 Imidazopyridin-2-one derivative
08/11/2011	WO2011096484A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
08/11/2011	WO2011096461A1 Quinoline derivative
08/11/2011	WO2011096377A1 Pyrrole compound
08/11/2011	WO2011096360A1 Method for treatment of lacto-n-biose-containing solution
08/11/2011	WO2011095556A1 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
08/11/2011	WO2011095495A1 Compositions and methods for inhibiting expression of ikk2 genes
08/11/2011	WO2011095452A1 Aryl benzylamine compounds
08/11/2011	WO2011034328A3 Composition including chlorophyll a as an active ingredient for preventing and treating th2-mediated immunological diseases
08/11/2011	WO2011022606A3 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
08/11/2011	US20110197292 Delivery method
08/11/2011	US20110196128 Murine zcytor17 ligand polynucleotides
08/11/2011	US20110196021 High Affinity Nucleic Acid Ligands of Complement System Proteins
08/11/2011	US20110196020 Treatment of chronic fatigue syndrome using selective agonists of toll-like receptor 3 (tlr3)
08/11/2011	US20110196016 Compositions and Methods for Inhibiting Expression of IKK2 Genes
08/11/2011	US20110196013 Animal feed composition
08/11/2011	US20110196004 Crystalline forms of (r) -5-[3-chloro-4-(2,3-dihydroxy-propoxy)-benz [z] ylidene] -2-( [z]-propylimino) -3-0-tolyl-thiazolidin-4-one
08/11/2011	US20110195959 Compositions And Methods Relating To Novel Compounds And Targets Thereof
08/11/2011	US20110195937 Oxidized thiophospholipid compounds and uses thereof
08/11/2011	US20110195918 Method for producing pectin hydrolysis products
08/11/2011	US20110195893 Use of apolipoproteins to decrease inflammation
08/11/2011	US20110195121 chronotherapeutic pharmaceutical dosage form
08/11/2011	US20110195115 Hydrophilic amino acid-containing preparation having improved taste
08/11/2011	US20110195113 Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
08/11/2011	US20110195094 Triazole compounds that modulate hsp90 activity
08/11/2011	US20110195091 Avian Influenza Virus Antigen, and Booster Immunization Method for Avian Influenza Vaccine in Combination with Mucosal Adjuvant Which is Effective Through Oral Administration
08/11/2011	US20110195089 Compositions, methods, and kits for enhancing the immunogenicity of pathogenic antigens
08/11/2011	US20110195087 Combination vaccine with whole cell pertussis
08/11/2011	US20110195086 15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
08/11/2011	US20110195084 Anti-HIV Vaccine Constructed Based on Amino Acid Mutations in Attenuated Live EIAV Vaccine
08/11/2011	US20110195083 Cyclic v3 peptides for anti hiv-1 vaccine
08/11/2011	US20110195082 Multimeric Complexes of Antigens and an Adjuvant
08/11/2011	US20110195081 Foxm1 peptide and medicinal agent comprising the same
08/11/2011	US20110195080 Compositions and Methods for Enhanced Somatostatin Immunogenicity in the Treatment of Growth Hormone and Insulin-Like Growth Factor One Deficiency
08/11/2011	US20110195079 Immunization protocol for directed expansion and maturation
08/11/2011	US20110195078 Tat-based immunomodulatory compositions and methods for their discovery and use
08/11/2011	US20110195077 Methods and compositions using fgf23 fusion ppolypeptides
08/11/2011	US20110195069 Inhibitors of complement activation
08/11/2011	US20110195068 Pd-1 antagonists and methods of use thereof
08/11/2011	US20110195067 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCy RECEPTORS
08/11/2011	US20110195063 Methods of Treating Ankylosing Spondylitis Using Anti-TNF Antibodies and Peptides of Human Tumor Necrosis Factor
08/11/2011	US20110195062 Mammalian Cytokines; Related Reagents and Methods
08/11/2011	US20110195055 Method and apparatus for holding cells
08/11/2011	US20110195048 Regulation of lymphocytes and uses therefor
08/11/2011	US20110195045 Methods, agents and peptides for inducing an immune response to matrix metalloproteinase-2 expressing tumors
08/11/2011	US20110195026 Protein
08/11/2011	US20110195023 Internalizing Anti-CD74 Antibodies and Methods of Use
08/11/2011	US20110195022 Cd20 antibodies and uses thereof
08/11/2011	DE102010026879A1 Transdermal system, useful for indicating and preventing multiple sclerosis, immunomodulator including quinolines or isoxazoles, metabolite forming groups, skin protective layer, a reservoir and a carrier impermeable to active substance
08/11/2011	CA2789001A1 Method for treatment of lacto-n-biose-containing solution
08/11/2011	CA2788902A1 Nucleic acid molecules encoding rantes, and compositions comprising and methods of using the same
08/11/2011	CA2788835A1 The use of pituitary adenylate cyclase-activating polypeptide (pacap) and pacap analogs as adjunctive treatments with inhibitors of calcineurin or inhibitors of the mammalian target of rapamycin (mtor) complexes
08/11/2011	CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
08/11/2011	CA2788071A1 Pyrrolo [ 2, 3 - d] pyrimidine urea compounds as jak inhibitors
08/11/2011	CA2787291A1 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds
08/10/2011	EP2354791A1 Immunocytokines with modulated selectivity
08/10/2011	EP2354160A1 Engineered anti-IL-23-antibodies
08/10/2011	EP2354152A1 Peptide antagonist of interleukin-15 activity
08/10/2011	EP2354149A1 Molecules with extended half-lives, compositions and uses thereof
08/10/2011	EP2354125A1 Anhydrous and hydrate polymorphic forms of antihistaminic piperidine derivatives
08/10/2011	EP2353599A1 8-hydroxyquinolines as inhibitors of cathepsin B
08/10/2011	EP2352816A1 Human progenitor t-cells
08/10/2011	EP2352732A1 2, 5-diamino-substituted pyrido ý4, 3-d¨pyrimidines as autotaxin inhibitors against cancer
08/10/2011	EP2352520A1 Vaccination with poxvirus vectors via mechanical epidermal disruption
08/10/2011	EP2352509A1 Hla-g proteins and pharmaceutical uses thereof
08/10/2011	EP2352492A2 Small molecule modulators of epigenetic regulation and their therapeutic applications
08/10/2011	EP1963484B1 Method of producing rough strains of bacteria and uses thereof
08/10/2011	EP1609781B1 Optical resolution of (1-benzyl-4-methylpiperidin-3-yl)-methylamine
08/10/2011	EP1602377B1 Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
08/10/2011	EP1507554B1 Lactoferrin in the treatment of malignant neoplasms and other hyperproliferative diseases
08/10/2011	EP1496873B2 Chewable soft capsule
08/10/2011	EP1212349B1 Recombinant subunit vaccine
08/10/2011	EP1190074B1 Recombinant anti-cd40 antibody and uses thereof
08/10/2011	EP1068296B1 Compositions for eliciting an immune response to a telomerase antigen
08/10/2011	CN1980937B Thienopyridone carboxamides and their medical use
08/10/2011	CN102149820A Cell capable of expressing exogenous GITR ligand
08/10/2011	CN102149729A Antibodies against FcRn and use thereof
08/10/2011	CN102146411A Novel bifunctional cicatrix and tissue fibrosis resistant oligonucleotide medicament
08/10/2011	CN102146142A Method for preparing astragalus polysaccharides
08/10/2011	CN102146132A Active polypeptide with antagonistic chemotactic factor receptor CCR5 and preparation method and application thereof
08/10/2011	CN102146074A Preparation method of pyrrole derivative and application thereof
08/10/2011	CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders
08/10/2011	CN102146026A Protosappanin A derivative and preparation method and application thereof
08/10/2011	CN102146014A Method for extracting squalene by using camellia oleosa seeds as raw materials and tea oil and squalene soft capsules
08/10/2011	CN102145179A Application of IL-1ra-Fcepsilon fusion gene and coded protein thereof to treatment on allergic rhinitis
08/10/2011	CN102145136A Chinese medical meridian physiotherapy liquid and preparation method and application thereof
08/10/2011	CN102145135A Process for extracting bamboo leaf coarse polysaccharide by supercritical CO2 fluid extraction technology

1 ... 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 ... 1172